Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
TSU-68 (SU6668, Orantinib) can potently inhibit FGFR1, PDGFRbeta, and Flk-1/KDR with Ki of 8 nM, 1200 nM and 2100 nM. More information please visit the website: http://www.creative-enzymes.com/product/TSU68-SU6668-_1962.html
Labeled Tamsulosin, intended for use as an internal standard for the quantification of Tamsulosin by GC- or LC-mass spectrometry.
A novel, centrally acting oral analgesic with a dual mode of action that has demonstrated efficacy in preclinical and clinical models of pain relief.;Labeled Tapentadol, intended for use as an internal standard for the quantification of Tapentadol by GC- or LC-mass spectrometry.
Labeled metabolite of Ticagrelor, intended for use as an internal standard for the quantification of Ticagrelor by GC- or LC-mass spectrometry.
Trifluorothymidine-13C,15N2 is an isotopic analog of Trifluorothymidine
Name Trimethoprim-D9 Cat# CPWBA263 Unlabeled CAS# NA Labeled CAS# 1189460-62-5 Molecular Weight NA Chemical Purity NA
https://www.creative-proteomics.com/cpwba263-product-trimethoprim-d9-30664.htm
Labeled Vardenafil, intended for use as an internal standard for the quantification of Vardenafil by GC- or LC-mass spectrometry.
Labelled Vilazodone is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression. Antidepressant.
Anhydrous form of a synthetic imidazole third generation bisphosphonate analog of pyrophosphate with antiresorptive activity. Zoledronate binds to hydroxyapatite crystals in the bone matrix and inhibits farnesyl pyrophosphate (diphosphate) synthase.
BOC Sciences manufactures thousands of pharmaceutical impurities, degradations, metabolites of active pharmaceutical ingredients, and excipients in accordance with the guidelines and limits described in the international pharmacopeia monographs for many impurities to serve drug development. In particular, BOC Sciences has access to rarely found degradations preparation standards for a number of OTC pharmaceuticals, which enables us to manufacture many degradations with ease; and occasionally we share the standards with our clients all over the world. We provide (+)-Cloprostenol. More information please visit the webiste: http://www.bocsci.com/im-CLOPROSTENOL-and-Impurities-list-646.html
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder